Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J van Hal

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 29, 2004
An HIV-positive man with generalized rashS J van Hal, G Kotsiou
HIV Medicine|January 27, 2005
Emergence of invasive cerebral aspergillosis in an HIV-positive patient on voriconazole therapyS J van Hal, K Clezy
The Journal of Infection|April 4, 2006
Not another case of endocarditis: recurrent prosthetic valve dehiscense in a Chinese manS J van Hal, B J Hudson
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 31, 2010
Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient--a review of the literatureS J van Hal, D L Paterson, I B Gosbell
Antimicrobial Agents and Chemotherapy|April 13, 2013
Reply to "Vancomycin-induced nephrotoxicity"S J van Hal, D L Paterson, T P Lodise
Annals of Hematology|January 11, 2014
Is there still a place for itraconazole prophylaxis in high-risk hematology patients?S J van Hal, S R Larsen, R C Chan
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 23, 2009
Voriconazole concentrations and outcome of invasive fungal infectionsS Miyakis, S J van Hal, J Ray, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 4, 2014
Impact of source of infection and vancomycin AUC0-24/MICBMD targets on treatment failure in patients with methicillin-resistant Staphylococcus aureus bacteraemiaN Ghosh, R Chavada, M Maley, et al.
Antimicrobial Agents and Chemotherapy|November 21, 2012
Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per literS J van Hal, D L Paterson, T P Lodise
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2012
The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysisS J van Hal, T P Lodise, D L Paterson
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 29, 2004
An HIV-positive man with generalized rashS J van Hal, G Kotsiou
HIV Medicine|January 27, 2005
Emergence of invasive cerebral aspergillosis in an HIV-positive patient on voriconazole therapyS J van Hal, K Clezy
The Journal of Infection|April 4, 2006
Not another case of endocarditis: recurrent prosthetic valve dehiscense in a Chinese manS J van Hal, B J Hudson
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 31, 2010
Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient--a review of the literatureS J van Hal, D L Paterson, I B Gosbell
Antimicrobial Agents and Chemotherapy|April 13, 2013
Reply to "Vancomycin-induced nephrotoxicity"S J van Hal, D L Paterson, T P Lodise
Annals of Hematology|January 11, 2014
Is there still a place for itraconazole prophylaxis in high-risk hematology patients?S J van Hal, S R Larsen, R C Chan
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 23, 2009
Voriconazole concentrations and outcome of invasive fungal infectionsS Miyakis, S J van Hal, J Ray, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 4, 2014
Impact of source of infection and vancomycin AUC0-24/MICBMD targets on treatment failure in patients with methicillin-resistant Staphylococcus aureus bacteraemiaN Ghosh, R Chavada, M Maley, et al.
Antimicrobial Agents and Chemotherapy|November 21, 2012
Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per literS J van Hal, D L Paterson, T P Lodise
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2012
The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysisS J van Hal, T P Lodise, D L Paterson
Pageof 3